Riskpilot← Back to searchSign inGet full accessJEV INVEST AS
ASActiveOrg 989544578Tuengen allé 22B, 0374 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
+77% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
NOK 1,3M
+33% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -666K | +77% |
| Net profit | NOK 1,3M | +33% |
| Total assets | NOK 44M | -2% |
| Equity | NOK 43,9M | +0% |
| Employees | 0 | — |
Legal name
JEV INVEST AS
Org number
989544578
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
22. mars 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie, utvikle og forvalte en investeringsportefølje bestående av verdipapirer, fast eiendom og andre aktiva, samt alt som hermed er forbundet, herunder å organisere porteføljen i konsern.
Address
Tuengen allé 22B, 0374 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −339 | −160 | −2 201 | −2 915 | −666 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −339 | −160 | −2 201 | −2 915 | −666 |
| Net financials | 2 119 | 33 185 | 17 | 3 869 | 2 028 |
| Profit before tax | 1 780 | 33 026 | −2 184 | 954 | 1 362 |
| Tax | −0 | −0 | −0 | −0 | 90 |
| Net profit | 1 780 | 33 026 | −2 184 | 954 | 1 272 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 279 | 46 502 | 44 093 | 44 813 | 44 011 |
| Equity | 15 276 | 46 491 | 44 079 | 43 761 | 43 883 |
| Long-term debt | 0 | 0 | 0 | 0 | 90 |
| Short-term debt | 3 | 11 | 14 | 1 052 | 38 |
| Total debt | 3 | 11 | 14 | 1 052 | 128 |
EBITDA margin
-66610400.0%
This company
15.8%
Market median
-421584910% vs market
20202024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20202024
Net profit margin
127168900.0%
This company
8.1%
Market median
+1569986320% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2023 | |
| Chairman | 2006 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JEV INVEST AS 
Epivity Health AsBoard members of JEV INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mimi Kristine Berdal | Board of Directors | 0 companies |
| Jan Einar Vaage | Chairman | 0 companies |
| Anders Berdal Vaage | Board of Directors | 0 companies |
| Ragnhild Marta Wiborg | Board of Directors | 0 companies |